Rui Avelar Biography and Net Worth

Insider of Evolus

Rui Avelar, M.D., has served as our Chief Medical Officer, and as the Chief Medical Officer of ALPHAEON, since January 2014. From March 2011 to December 2013, he served as Chief Medical Officer of Allergan Medical, where he was responsible for clinical development, clinical operations, safety, medical writing, biostatistics and regulatory matters. Dr. Avelar holds a M.D. from the University of Toronto and has received training accreditation in Sports Medicine from the Canadian Academy of Sports Medicine.

What is Rui Avelar's net worth?: The estimated net worth of Rui Avelar is at least $3.91 million as of March 18th, 2025. Dr. Avelar owns 362,467 shares of Evolus stock worth more than $3,911,019 as of April 18th. This net worth estimate does not reflect any other investments that Dr. Avelar may own. Additionally, Dr. Avelar receives a salary of $823,190.00 as Insider at Evolus. Learn More about Rui Avelar's net worth.
How old is Rui Avelar?: Dr. Avelar is currently 62 years old. There are 2 older executives and no younger executives at Evolus. Learn More on Rui Avelar's age.
What is Rui Avelar's salary?: As the Insider of Evolus, Inc., Dr. Avelar earns $823,190.00 per year. The highest earning executive at Evolus is Mr. David Moatazedi, President, CEO & Director, who commands a salary of $1,750,000.00 per year. Learn More on Rui Avelar's salary.
How do I contact Rui Avelar?: The corporate mailing address for Dr. Avelar and other Evolus executives is 520 Newport Center Dr. Suite 1200, Newport Beach CA, 92660. Evolus can also be reached via phone at (949) 284-4555 and via email at ir@evolus.com. Learn More on Rui Avelar's contact information.
Has Rui Avelar been buying or selling shares of Evolus?: Rui Avelar has not been actively trading shares of Evolus during the past quarter. Most recently, Rui Avelar sold 27,904 shares of the business's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $13.26, for a transaction totalling $370,007.04. Following the completion of the sale, the insider now directly owns 362,467 shares of the company's stock, valued at $4,806,312.42. Learn More on Rui Avelar's trading history.
Who are Evolus' active insiders?: Evolus' insider roster includes Rui Avelar (Insider), David Gill (Director), David Gill (Director), Vikram Malik (Director), David Moatazedi (Insider), and Tomoko Yamagishi-Dressler (CMO). Learn More on Evolus' active insiders.
Are insiders buying or selling shares of Evolus?: During the last twelve months, insiders at the sold shares 14 times. They sold a total of 258,215 shares worth more than $3,359,057.01. The most recent insider tranaction occured on March, 27th when insider David Moatazedi sold 6,251 shares worth more than $77,512.40. Insiders at Evolus own 6.1% of the company. Learn More about insider trades at Evolus.
Information on this page was last updated on 3/27/2025.

Rui Avelar Insider Trading History at Evolus

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/18/2025	Sell	27,904	$13.26	$370,007.04	362,467
12/23/2024	Sell	2,252	$10.85	$24,434.20	366,595
3/19/2024	Sell	27,603	$13.92	$384,233.76	372,288
8/16/2023	Sell	2,211	$10.27	$22,706.97	353,386
8/10/2021	Sell	14,293	$11.18	$159,795.74	209,810
1/7/2020	Sell	39,442	$10.71	$422,423.82	70,802

Rui Avelar Buying and Selling Activity at Evolus

Evolus Company Overview

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Today's Range

Now: $10.79

$10.33

$10.97

50 Day Range

MA: $12.62

$9.36

$15.04

2 Week Range

Now: $10.79

$8.67

$17.82

Volume

1,051,617 shs

Average Volume

660,105 shs

Market Capitalization

$686.10 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.97

Rui Avelar Biography and Net Worth

What is Rui Avelar's net worth?

How old is Rui Avelar?

What is Rui Avelar's salary?

How do I contact Rui Avelar?

Has Rui Avelar been buying or selling shares of Evolus?

Who are Evolus' active insiders?

Are insiders buying or selling shares of Evolus?